Skip to main content
Apptad
  • Capabilities
  • Industries
  • Alliances
  • Outcomes
  • Insights
  • Company
  • Careers
  • Contact Us
Data Governance Trends 2025 – 2026: An Apptad Prespective
Insights/Data Governance & Quality
Data Governance & Quality

Data Governance Trends 2025 – 2026: An Apptad Prespective

By Apptad· Jul 22, 2025· 1 min read
Share

Data-Governance-Trends-2025-2026-An-Apptad-Perspective (opens in new tab)Download (opens in new tab)

Filed under
Data Governance & Quality
Found this useful? Share it.
LinkedInX / TwitterEmail
More to Read

Related Insights

AI chatbot using prompt engineering and LLM deep learning delivers explainable generative AI for smarter, more efficient business support. Latch
AI & Agentic AI

From Black Box to Glass Box: A Practical Playbook for Explainable AI

AI you can't explain is AI you can't deploy. A risk-tiered playbook for explainable AI in 2026 — from SHAP and counterfactuals to reasoning traces for autonomous agents — built for the new regulatory reality.

Jun 28, 2026 5 min
Financial Analyst looking at computer screen analyzing data
Industry Insights

Intelligent Data Stewardship for Financial Services

Master data stewardship in a bank always ran on a queue a human had to clear. In 2026 that changed: Reltio shipped autonomous stewardship agents, Informatica announced the first Agentic Multidomain MDM, and SAP acquired Reltio to anchor its AI strategy. This piece maps where autonomous stewardship lands first in financial services — KYC onboarding, AML golden sources, BCBS 239 risk-data aggregation, and reference data — why the data foundation still decides the outcome (99% plan agents, only 11% are in production), and how the steward's role moves from clearing queues to governing exceptions.

Jun 12, 2026 14 min
Life sciences data fabric: patient, drug, and provider master data feeding a federated RWE study layer that flows up to FDA submissions.
Industry Insights

Real World Evidence at Scale: The Data Foundation FDA Is Now Demanding

In March 2026 the FDA adopted ICH M14, completing real-world evidence's transition into a first-class regulatory pathway. Roughly a quarter of FDA label expansions in 2022-2024 were supported by RWE, with oncology driving nearly half of those approvals. The shift has exposed a structural problem: the data foundation underneath RWE — patient master, drug master, provider master, and cross-source identity resolution — is not ready for the standard the agency is now applying. This piece explains why RWE at scale is a master data problem, not an analytics one, and what pharma data and regulatory leaders should do in their next ninety days.

Jun 7, 2026 14 min
Put Insights to Work

Ready to apply these ideas to your business?

Tell us where you're stuck. A senior consultant will reply within one business day with a concrete next step.

Talk to an ExpertExplore Capabilities
Apptad

A strategic data, AI, and enterprise transformation partner — onshore advisory, global delivery, measurable outcomes.

LinkedIninfo@apptadinc.com

Solutions

  • Capabilities
  • Industries
  • Alliances

Resources

  • Outcomes
  • Insights

Company

  • Company
  • Careers
  • Suppliers
  • Contact

APPTAD TECHNOLOGIES PRIVATE LIMITED · CIN: U72200KA2015PTC081162

Registered Office: No. 1562, Ground Floor, 4th Cross, Nagappa Block, Srirampuram, Bengaluru, Karnataka 560021, India

Tel: +91 0120 4366 509 · Email: info@apptadinc.com · Grievance Officer: Ravi Shekhar, Director

APPTAD BRASIL LTDA · CNPJ: 67.907.474/0001-92

Sede (Registered Office): R. Prof. José Leite e Oiticica, 530, Vila Gertrudes, São Paulo – SP, CEP 04705-080, Brasil

Tel: +55 800 000 3704 · Email: info@apptadinc.com · Encarregado de Dados / Data Protection Contact (LGPD, Lei nº 13.709/2018): info@apptadinc.com

APPTAD LTD · Company No. 16267588 · Registered in England and Wales

Registered Office: 167-169 Great Portland Street, 5th Floor, London W1W 5PF, United Kingdom

Tel: +44 800 058 4301 · Email: info@apptadinc.com

© 2026 Apptad Inc. All rights reserved. Various trademarks held by their respective owners.

PrivacyTermsCookiesGDPRCCPA / CPRAInformation SecurityAnti-Bribery & CorruptionAccessibilityESG ReportLCA Filings (USCIS)
Ask about this article…